18F-FDG-PET/CT based total metabolic tumor volume change during neoadjuvant chemotherapy predicts outcome in advanced epithelial ovarian cancer

T. Vallius; J. Hynninen; J Hyninen; J. Kemppainen; V. Alves; K. Auranen; J. Matomäki; S. Oksa; J. Virtanen; S. Grénman; A. Auranen; M. Seppänen

doi:10.1007/s00259-018-3961-z

18F-FDG-PET/CT based total metabolic tumor volume change during neoadjuvant chemotherapy predicts outcome in advanced epithelial ovarian cancer

T. Vallius, J. Hynninen, J Hyninen, J. Kemppainen, V. Alves, K. Auranen, J. Matomäki, S. Oksa, J. Virtanen, S. Grénman, A. Auranen, M. Seppänen

Research output: Contribution to journal › Article › Scientific › peer-review

38 Citations (Scopus)

Original language	English
Pages (from-to)	1224-1232
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Volume	45
Issue number	7
DOIs	https://doi.org/10.1007/s00259-018-3961-z
Publication status	Published - 2018
Publication type	A1 Journal article-refereed

Keywords

18F-FDG-PET/CT
Neoadjuvant chemotherapy
Ovarian cancer
Total metabolic tumor volume
Treatment response

Publication forum classification

Publication forum level 2

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00259-018-3961-z

Cite this

Vallius, T., Hynninen, J., Hyninen, J., Kemppainen, J., Alves, V., Auranen, K., Matomäki, J., Oksa, S., Virtanen, J., Grénman, S., Auranen, A., & Seppänen, M. (2018). 18F-FDG-PET/CT based total metabolic tumor volume change during neoadjuvant chemotherapy predicts outcome in advanced epithelial ovarian cancer. European Journal of Nuclear Medicine and Molecular Imaging, 45(7), 1224-1232. https://doi.org/10.1007/s00259-018-3961-z

@article{e08cd80f6ec84565930ee2375ae1e870,

title = "18F-FDG-PET/CT based total metabolic tumor volume change during neoadjuvant chemotherapy predicts outcome in advanced epithelial ovarian cancer",

keywords = "18F-FDG-PET/CT, Neoadjuvant chemotherapy, Ovarian cancer, Total metabolic tumor volume, Treatment response, 18F-FDG-PET/CT, Neoadjuvant chemotherapy, Ovarian cancer, Total metabolic tumor volume, Treatment response",

author = "T. Vallius and J. Hynninen and J Hyninen and J. Kemppainen and V. Alves and K. Auranen and J. Matom{\"a}ki and S. Oksa and J. Virtanen and S. Gr{\'e}nman and A. Auranen and M. Sepp{\"a}nen",

year = "2018",

doi = "10.1007/s00259-018-3961-z",

language = "English",

volume = "45",

pages = "1224--1232",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

publisher = "Springer Verlag",

number = "7",

}

Vallius, T, Hynninen, J, Hyninen, J, Kemppainen, J, Alves, V, Auranen, K, Matomäki, J, Oksa, S, Virtanen, J, Grénman, S, Auranen, A & Seppänen, M 2018, '18F-FDG-PET/CT based total metabolic tumor volume change during neoadjuvant chemotherapy predicts outcome in advanced epithelial ovarian cancer', European Journal of Nuclear Medicine and Molecular Imaging, vol. 45, no. 7, pp. 1224-1232. https://doi.org/10.1007/s00259-018-3961-z

18F-FDG-PET/CT based total metabolic tumor volume change during neoadjuvant chemotherapy predicts outcome in advanced epithelial ovarian cancer. / Vallius, T.; Hynninen, J.; Hyninen, J et al.
In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, No. 7, 2018, p. 1224-1232.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - 18F-FDG-PET/CT based total metabolic tumor volume change during neoadjuvant chemotherapy predicts outcome in advanced epithelial ovarian cancer

AU - Vallius, T.

AU - Hynninen, J.

AU - Hyninen, J

AU - Kemppainen, J.

AU - Alves, V.

AU - Auranen, K.

AU - Matomäki, J.

AU - Oksa, S.

AU - Virtanen, J.

AU - Grénman, S.

AU - Auranen, A.

AU - Seppänen, M.

PY - 2018

Y1 - 2018

KW - 18F-FDG-PET/CT

KW - Neoadjuvant chemotherapy

KW - Ovarian cancer

KW - Total metabolic tumor volume

KW - Treatment response

KW - 18F-FDG-PET/CT

KW - Neoadjuvant chemotherapy

KW - Ovarian cancer

KW - Total metabolic tumor volume

KW - Treatment response

U2 - 10.1007/s00259-018-3961-z

DO - 10.1007/s00259-018-3961-z

M3 - Article

SN - 1619-7070

VL - 45

SP - 1224

EP - 1232

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

IS - 7

ER -